Post-approval studies (Phase 4)Study completedNCT01971606
What this trial is testing
Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study
Who this might be right for
A Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.
Yonsei University 234